Nov 11 delist notice will be sent out by Naz, Nov 12, no earnings or sales, but the reverse split talks start again... This is a poorly managed company with limited prospects. The ONLY way this company stays solvent is a FDA approval of a pipe dream product.. I feel sorry for the investors that exercised the $1.25 and $1.00 options to buy.. Threw their $$ down the rabbit hole it appears..
When DARA traded above $1 during September-October it re-established minimum bid requirements. Since it fell below again, I guess DARA has another 180 days to get stock above $1. Maybe company should have not cancelled reverse split meeting.
Mitch2bdog, hope it works out for you, but it is like investing in lottery tickets. Hope you diversify and invest in some better companies. I do not expect much from DARA's earnings report which will probably come out next week. Company burned at least $1 million-$2 million. Some SEC filing at end of September said they had in excess of $8 million cash after $1.2 million warrants excercised. Company had around $8 million cash last quarter.
Anyway, I think Soltamox is mostly useless drug and pipeline seems pretty weak. Generic cancer drugs seem pretty competitive. It will take around 3 years to get generic Gemzar approved after filing.
I have no position, long or short, and no desire to take one in DARA.
SSSHHHH....be very, very quiet we don't want to wake the sleeping giant before it's time. I quietly loaded more shares this week, yipppee. Pay attention grass hopper...earnings release next week along with news (Mitch says so)......ssshhhhh "development and commercialization of cancer support therapeutics".....be very quiet until then. Communicate your critical remarks w/ Bob and Whizzzhole, I hear some string and cans work well....keep the chatter to a low roar while the giant sleeps....later